logo-loader

Milestone Scientific names medical device expert Jan Adriaan Haverhals CEO of its dental subsidiary

Published: 15:15 02 Jun 2020 BST

Handshake
Haverhals is replacing Gian Domenico, who will remain on Milestone Scientific’s board of directors

Milestone Scientific Inc (NYSEAMERICAN:MLSS) has appointed a new chief executive for its subsidiary Wand Dental Inc, a 30-year medical device and pharmaceutical veteran, Jan Adriaan (Arjan) Haverhals.

Haverhals was previously senior vice president of sales at Xcentric Mold & Engineering, where he increased sales productivity and efficiency for its prototype injection molding services, which included work with leading healthcare clients.

He also held a series of senior sales and marketing roles at Straumann LLC, a manufacturer of medical and dental devices. His most notable role was vice president of customer marketing and education at Straumann, where he led the launch of more than 30 products in North America and oversaw double-digit growth.

READ: Milestone Scientific says seeing growing interest in its CompuFlo CathCheck System

Haverhals is replacing Gian Domenico, who will remain on Milestone Scientific’s board of directors.

"I am very pleased to announce the appointment of Arjan as President and CEO of our dental subsidiary,” Milestone CEO Leonard Osser said in a statement. "We thank Gian Domenico for his commitment as CEO of Wand Dental and look forward to his ongoing support of Arjan in his new leadership role."

Osser added: “We believe having such a strategic global growth leader will support our initiative to more aggressively market our dental instruments and handpieces on a global basis over the coming years as we evaluate new collaboration and distribution opportunities. Additionally, we look forward to Arjan's contributions as we commercialize our CompuFlo Epidural Instrument in the US and abroad."

Milestone’s CompuFlo system is a computer-controlled, real-time pressure-sensing technology designed to reduce failure rates and accidental punctures from epidural catheters.

"I am thrilled to accept this position and look forward to helping grow Wand Dental, as well as accelerate the launch of the CompuFlo Epidural Instrument and other medical products based on the proprietary Dynamic Pressure Sensing Technology technology,” Haverhals said. 

“I'm impressed with The Wand's existing foothold within the market, and opportunities for growth. With the right focus, I believe we can help bring this business to the next level. At the same time, I look forward to supporting the growth of the CompuFlo Epidural Instrument in both the domestic and international markets," the new boss added.

Contact Andrew Kessel at andrew.kessel@proactiveinvestors.com

Follow him on Twitter @andrew_kessel

FTSE rises ahead of Easter weekend, JD Sport gains on upbeat outlook -...

The FTSE 100 gained on the final morning of this shortened Easter trading week. Festive cheer was limited though, as Thames Water confirmed shareholders would not provide it with a £500 million rescue package, prompting speculation over the London supplier’s future. On a more positive...

1 hour, 36 minutes ago